相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between resistin gene -420 C/G polymorphism and the risk of type 2 diabetes mellitus: a meta-analysis
Ying Wen et al.
ACTA DIABETOLOGICA (2013)
Association of circulating levels of nicotinamide phosphoribosyltransferase (NAMPT/Visfatin) and of a frequent polymorphism in the promoter of the NAMPT gene with coronary artery disease in diabetic and non-diabetic subjects
Pedro Saddi-Rosa et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Association of resistin gene polymorphisms with insulin resistance in Egyptian obese patients
Amal S. El-Shal et al.
GENE (2013)
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
Tania Romacho et al.
MEDIATORS OF INFLAMMATION (2013)
Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile
T. D. Filippatos et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2013)
Serum Resistin, Cardiovascular Disease and All-Cause Mortality in Patients with Type 2 Diabetes
Claudia Menzaghi et al.
PLOS ONE (2013)
Resistin: functional roles and therapeutic considerations for cardiovascular disease
Md S. Jamaluddin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction
Karin Leander et al.
CLINICA CHIMICA ACTA (2012)
Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus
Sema Uslu et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2012)
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review
Yu-Hung Chang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus
Hala O. El-Mesallamy et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Genetic variant in visfatin gene promoter is associated with decreased risk of coronary artery disease in a Chinese population
Jian-Jun Yan et al.
CLINICA CHIMICA ACTA (2010)
Visfatin/PBEF and Atherosclerosis-Related Diseases
Theodosios D. Filippatos et al.
CURRENT VASCULAR PHARMACOLOGY (2010)
Genetic variation in the visfatin (PBEF1/NAMPT) gene and type 2 diabetes in the Greek population
Peristera Paschou et al.
CYTOKINE (2010)
Global estimates of the prevalence of diabetes for 2010 and 2030
J. E. Shaw et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Resistin gene promoter region polymorphism and the risk of hypertrophic cardiomyopathy in patients
Sabir Hussain et al.
TRANSLATIONAL RESEARCH (2010)
Visfatin, glucose metabolism and vascular disease: a review of evidence
Pedro Saddi-Rosa et al.
DIABETOLOGY & METABOLIC SYNDROME (2010)
Association of Variants in RETN With Plasma Resistin Levels and Diabetes-Related Traits in the Framingham Offspring Study
Marie-France Hivert et al.
DIABETES (2009)
Polymorphism in resistin promoter region at-420 determines the serum resistin levels and may be a risk marker of stroke in Japanese type 2 diabetic patients
Takayoshi Tsukahara et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
The+299(G > A) Resistin Gene Polymorphism and Susceptibility to Type 2 Diabetes in Thais
Kanjana Suriyaprom et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2009)
Resistin gene variations are associated with the metabolic syndrome in Japanese men
Yoshihiro Miyamoto et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2009)
Role of adipocytokines in predicting the development of diabetes and its late complications
Nese Ersoz Gulcelik et al.
ENDOCRINE (2009)
Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: The Korean atherosclerosis study (KAS) A 42-month prospective study
Soo Lim et al.
ATHEROSCLEROSIS (2008)
A polymorphism in the resistin gene promoter and the risk of coronary artery disease in a Chinese population
Na-Ping Tang et al.
CLINICAL ENDOCRINOLOGY (2008)
Adipokines: The missing link between insulin resistance and obesity
B. Antuna-Puente et al.
DIABETES & METABOLISM (2008)
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Gideon R. Hajer et al.
EUROPEAN HEART JOURNAL (2008)
Associations of adiponectin, resistin, and tumor necrosis factor-α with insulin resistance
Marie-France Hivert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity
Tracy Luk et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
The visfatin (PBEF1) G-948T gene polymorphism is associated with increased high-density lipoprotein cholesterol in obese subjects
Lina M. Johansson et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Genetic variants at the resistin locus are associated with the plasma resistin concentration and cardiovascular risk factors
Olavi Ukkola et al.
REGULATORY PEPTIDES (2008)
Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retraction of vol 307, pg 426, 2005)
Atsunori Fukuhara et al.
SCIENCE (2007)
Plasma resistin, associated with single nucleotide polymorphism-420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population
Haruhiko Osawa et al.
DIABETES CARE (2007)
Effects of genetic variation in the visfatin gene (PBEF1) on obesity, glucose metabolism, and blood pressure in children
Antje Koerner et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus
Yoshiharu Tokuyama et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study
Jian Yu Xu et al.
CLINICAL ENDOCRINOLOGY (2007)
Plasma resistin levels correlate with determinants of the metabolic syndrome
G. D. Norata et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Insulin-like effects of visfatin on human osteoblasts
H. Xie et al.
CALCIFIED TISSUE INTERNATIONAL (2007)
A visfatin promoter polymorphism is associated with low-grade inflammation and type 2 diabetes
Yuan-Yuan Zhang et al.
OBESITY (2006)
Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population
Swneke D. Bailey et al.
DIABETES (2006)
Genetic variation in the visfatin gene (PBEF1) and its relation to glucose metabolism and fat-depot-specific messenger ribonucleic acid expression in humans
Yvonne Boettcher et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians
Claudia Menzaghi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Adipose tissue - From lipid storage compartment to endocrine organ
Philipp E. Scherer
DIABETES (2006)
Resistin
PG McTernan et al.
CURRENT OPINION IN LIPIDOLOGY (2006)
被撤回的出版物: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
A Fukuhara et al.
SCIENCE (2005)
Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects
KN Conneely et al.
DIABETOLOGIA (2004)
Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes
A Fujinami et al.
CLINICA CHIMICA ACTA (2004)
Resistin release by human adipose tissue explants in primary culture
JN Fain et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
分享论文
